Sort by
Refine Your Search
-
Listed
-
Field
-
to vaccine development utilizing viral vectors to contribute to an effort in developing neoantigen expressing vaccines for clinical investigations. The position is available as part of a multi-disciplinary
-
contribute to innovative research improving cancer patient outcomes. · Professional development support including conference attendance and publication opportunities. · Access to state
-
Pal, please visit here . For a complete list of Dr. Pal’s publications please visit here . As a successful candidate you will: · Develop and maintain clinical and translational research trials
-
small and long noncoding RNAs to the regulation of gene expression during development and functioning of the immune system. Besides being fundamentally important, this work can potentially shed light on
-
successful candidate, you will: This project with Dr. Nagarajan Vaidehi involves developing and application of interpretable machine learning methods to uncover allosteric regulation of disordered regions in
-
the Department of Hematological Malignancies Translational Science, Department of Pediatrics, and Gehr Family Center for Leukemia Research. You will directly work on the following projects: 1) Development
-
highly motivated postdoctoral fellow to study transcriptional regulation and RNA metabolism in normal development and human diseases, such as neurological disorder, immunology, and cancer. In particular
-
studies. The lab focuses on mechanisms underlying human T-cell development and lymphoid leukemogenesis and the application of these mechanistic insights to the development of novel anti-cancer immunotherapy
-
. This project involves the development and application of interpretable machine learning methods to uncover allosteric regulation of disordered regions in the dynamics of G-protein coupled receptors to enable
-
tools to identify novel signaling pathways to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in regulating both normal